Skip to content
2000
Volume 15, Issue 4
  • ISSN: 1871-5303
  • E-ISSN: 2212-3873

Abstract

Spasticity is a motor disorder with an increased muscle tone, typically associated with spasms, weakness and lack of coordination. It is an invalidating and debilitating pathology, characterized by pain, limited autonomy in activities of daily living, development of severe lesions. Spasticity can be adequately treated with physiotherapy, muscle relaxants drugs or topical treatment with botulinic toxin type A. Intrathecal baclofen therapy is very effective in the treatment of severe and generalized spasticity. Sometimes, soft tissues adjacent to the implant intrathecal infusion become infected; removing intrathecal infusion and systemic antibiotic therapy are best solution for clinical cure. However, removing intrathecal baclofen therapy could increase muscle spasticity with enhancement of pain and clonus that can worsen quality of life. In this study, we evaluated clinical improvement after complete healing of the septic focus and implantation of a new infuser.

Loading

Article metrics loading...

/content/journals/emiddt/10.2174/1871530315666150506124127
2015-12-01
2025-05-22
Loading full text...

Full text loading...

/content/journals/emiddt/10.2174/1871530315666150506124127
Loading

  • Article Type:
    Research Article
Keyword(s): Antibiotic therapy; baclofen; clonus; infection; intrathecal infusion; spasticity
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test